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Extrahepatic cholangiocarcinoma is often clinically challenging to diagnose. Even multidisciplinary approaches 
which include computed tomography, magnetic resonance imaging, and endoscopic retrograde cholangiography are 
unsatisfactory in some cases, especially with biliary stricture. Percutaneous transhepatic cholangioscopy (PTCS) with its 
direct visualization for biopsy appears to be a promising technique for detecting cholangiocarcinoma at an early stage. 
We report a case of adenocarcinoma in situ of the distal common bile duct (CBD) that was confirmed by PTCS. This case 
suggests the useful role of PTCS in the differential diagnosis of a distal CBD obstruction, particularly when other diagnostic 
modalities do not provide definitive information. 
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INTRODUCTION
Cholangiocarcinoma accounts for almost 3% of all gas-
trointestinal cancers [1], and about one-fourth of cases 
with cholangiocarcinoma are distal extrahepatic cholan-
giocarcinomas [2]. Patients with cholangiocarcinoma typi-
cally present at advanced stages, and the cure rate is low, 
even with aggressive therapy [3]. The diagnosis of chol-
angiocarcinoma requires a multidisciplinary approach, 
which consists of high clinical suspicion in combination 
with appropriate imaging studies such as computed to-
mography (CT), magnetic resonance imaging (MRI) with 
cholangiopancreatography, percutaneous transhepatic 
cholangiography, and endoscopic retrograde cholangio-
pancreatography (ERCP) [3]. Percutaneous transhepatic 
cholangioscopy (PTCS) or peroral cholangioscopy appears 
to be a promising technique for detecting cholangiocarci-
noma at an early stage [2]. We report the case of a patient 
with an adenocarcinoma in situ of the distal common bile 
duct (CBD) that was confirmed by PTCS.
CASE REPORT
A 55-year-old man was referred to our hospital for the 
evaluation of the obstruction of the distal CBD. 
He had visited to a local hospital due to right upper 
quadrant pain, jaundice, and clay-colored stools for 1 
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week. An abdominal CT revealed a distended gallblad-
der with dilated intrahepatic and extrahepatic bile ducts 
(Fig. 1). The laboratory data were consistent with obstruc-
tive jaundice. Percutaneous transhepatic biliary drainage 
(PTBD) was performed, and the right upper quadrant pain 
was relieved. ERCP revealed a filling defect at the distal 
CBD with bile sludge. No stone was found. The patient was 
referred to our hospital for further evaluation and treat-
ment.
No medical history of hypertension, diabetes mellitus, 
tuberculosis, or chronic liver disease was identified, and 
he denied smoking and alcohol intake. On admission, the 
vital signs were within normal ranges. No jaundice was 
observed in his conjunctiva. There was no palpable mass 
or tenderness in the abdomen. Laboratory test results 
included the following: white blood cell count, 6,790/μL; 
Figure 1. Portal-phase computed tomography scans show the distended gallbladder with both intrahepatic bile duct and common bile 
duct dilatation (white arrow), which is suggestive of obstructive jaundice. However, there is no obstructive lesion such as an abnormal 
enhancing lesion or eccentric wall thickening at the distal common bile duct.
B a
Figure 2. (A) Percutaneous transhepatic cholangiogram, and (B) endoscopic retrograde cholangiopancreatogram show a suspicious 
small contrast filling defect at the distal common bile duct (white arrow), but no definite obstructive lesion in the common bile duct.
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hemoglobin level, 13.8 g/dL; platelet count, 330 k/μL; se-
rum creatinine, 1.1 mg/dL; blood urea nitrogen, 11 mg/dL; 
serum total bilirubin, 1.0 mg/dL; alkaline phosphatase, 
112 IU/L; aspartate aminotransferase, 44 IU/L; alanine 
aminotranferase, 89 IU/L; serum amylase, 56 U/L; and 
C-reactive protein, 1.43 mg/dL. The serum hepatitis B sur-
face antigen and serum hepatitis C antibodies were nega-
tive, and the serum levels of carcinoembryonic antigen 
and carbohydrate antigen 19-9 were 1.0 ng/mL and 22 U/
mL, respectively.
Abdominal CT revealed biliary decompression, but 
failed to demonstrate an obstructive lesion at the CBD, 
such as a stone or mass. A filling defect in the distal CBD 
was noted on a cholangiogram obtained through a PTBD 
tube (Fig. 2A); cellblock cytology of the bile drained 
through the tube was negative for malignant cells. The 
ERCP demonstrated a suspicious polypoid lesion at the 
distal CBD consistent with the previous cholangiogram; 
therefore, we performed a retrieval balloon sweep to 
evaluate whether a stone was in the CBD, and a biopsy was 
conducted (Fig. 2B). No stone was found in the CBD, but 
a microscopic examination of the duodenoscopic biopsy 
specimen showed high-grade epithelial dysplasia. PTCS 
was performed to determine a definitive diagnosis. A 1.0 × 
1.0 cm polypoid lesion was visualized at the distal CBD on 
PTCS (Fig. 3). Adenocarcinoma in situ was confirmed af-
ter a pathology examination of the PTCS biopsy specimen.
With the diagnosis of adenocarcinoma in situ of the 
distal CBD, a laparoscopic pylorus-preserving pancreati-
coduodenectomy was conducted. The resection margins of 
the bile duct and the pancreatic duct were confirmed nega-
tive for cancer cells by microscopic examination of frozen 
sections. A macroscopic examination of the resected speci-
men revealed a 1.8 × 1.5 cm elevated mass around the dis-
tal CBD adjacent to the ampulla of Vater. Microscopically, 
a papillary carcinoma that had developed in the bile duct 
was noted without features of lamina propria invasion and 
lymph node metastases (Fig. 4, pathologic TisN0 accord-
ing to the TNM staging system). The patient remained 
healthy, with no evidence of recurrence 3 months after the 
resection.
DISCUSSION
According to cancer incidence data between 1999 and 
2002 from the Korea Central Cancer Registry and In-
ternational Agency for Research on Cancer, extrahepatic 
cholangiocarcinoma, including gallbladder cancer, is the 
seventh most common cancer in men and the eighth most 
common in women. The crude incidence rate per year is 6.8 
and 6.9 cases per 100,000 Korean males and females, re-
spectively [4]. The majority of cases occur in patients older 
than 65 years of age and the peak incidence is during the 
seventh decade of life [3].
In general, extrahepatic cholangiocarcinomas have a 
poor prognosis, with an overall five-year survival rate of 
10-20% [1,3]. This is because most cases are locally ad-
vanced at presentation. In one large series, although a re-
section with negative margins was possible in 78% of cas-
es, lymph node involvement was observed in 60% of the 
patients [5]. According to Korean report, resectability rate 
was 56%, and stage III or more disease is present in about 
60% of the patients who undergo resection [6]. To improve 
Figure 3. On percutaneous transhepatic cholangioscopy, a 1 × 1 cm polypoid lesion was visualized in the distal common bile duct.
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the long-term survival of patients with extrahepatic chol-
angiocarcinoma, efforts should be directed toward early 
detection in patients presenting with obstructive jaundice.
The most common presenting symptoms of extrahepatic 
cholangiocarcinoma are jaundice (90%), pruritus (66%), 
abdominal pain (30-50%), weight loss (30-50%), and fever 
(up to 20%) [3]. Imaging studies for the diagnosis of ex-
trahepatic cholangiocarcinoma include ultrasonography, 
CT, MRI, PTC, and ERCP. Preoperative tissue diagnosis is 
difficult because of the intense desmoplastic nature of the 
tumor [2,7]. Brush cytology and intraductal biopsies have a 
sensitivity < 50% [7]. Therefore, biliary endoscopy, with its 
direct visualization for biopsy, is often a good diagnostic 
tool for a definite diagnosis in patients who are suspicious 
for biliary tract cancer [8].
Since first introduced by Takada et al. in 1974 PTCS has 
been utilized to manage a variety of biliary tract disorders 
[9]. The introduction of small-caliber flexible cholangio-
scopes in 1976 by Yamakawa et al. further enhanced the 
application of this technique [9]. PTCS has been used to 
manage diverse biliary tract disorders, including intra-
hepatic calculi removal, dilatation of intrahepatic biliary 
strictures, and the evaluation of suspected bile duct can-
cers [9]. Several reports have suggested that PTCS can 
improve biopsy accuracy [8-10]. One large study reported 
that percutaneous cholangioscopic biopsy had a sensitiv-
ity of 82.4% for the diagnosis of cholangiocarcinoma [8]. 
Nimura [10] reported that a PTCS-directed biopsy had 
a sensitivity of 96% for diagnosing cholangiocarcinoma. 
These results are significantly better than those reported 
for fluoroscopically guided biopsies [9]. In the present 
case, the lesion was too small to be detected on abdominal 
CT. Although the ERCP revealed a suspicious filling defect 
in the distal CBD, the ERCP-directed biopsy failed to pro-
vide a precise diagnosis. PTCS visualized a polypoid lesion 
that was a high-grade dysplasia by ERCP-directed biopsy, 
and enabled more accurate biopsy and early diagnosis of a 
cholangiocarcinoma in situ. 
In conclusion, extrahepatic cholangiocarcinoma is still 
clinically challenging to diagnose. When a cholangiocarci-
noma is clinically suspected on abdominal CT or a cholan-
giogram but the results are not definitive, a PTCS and bi-
Figure 4. (A) The biopsy specimen obtained by percutaneous 
transhepatic cholangioscopy consisted of three tiny pieces of neo-
plastic biliary mucosa characterized by complex glandular struc-
tures lined by stratified neoplastic columnar epithelium (H&E, 
× 100). (B) High-power magnification demonstrates the loss of 
polarity of the surface lining, the nuclei occupying the entire thick-
ness of the epithelium, and the architectural complexity shown by 
the back-to-back arrangement of the glandular structures (H&E, × 
200). (C) A low power view of the laparoscopic pylorus preserving 
pancreaticoduodenectomy specimen demonstrates the elevated 
mass in the common bile duct, without definite features of lamina 
propria invasion (H&E, × 100).
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opsy are a safe and effective approach for a more accurate 
and earlier diagnosis. 
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